WELCOME!

Our research focuses on developing synthetic nanoplatforms to direct immune cells as ‘living therapeutics’, through genetically programming cellular functions or molecularly targeting stimulatory/inhibitory pathways. To this end, our lab integrates nanotechnology, immunology, and clinically-relevant animal disease models to create novel nanotherapeutics for controlled modulation of the immune system. Our team creates a unique working environment by fostering interdisciplinary and translational collaboration.